Los Angeles Capital Management
ARIA

Los Angeles Capital Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Los Angeles Capital Management’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-14,545
Closed -$107K – 1318
2016
Q2 		$107K Buy
+14,545
New +$109K ﹤0.01% 1206
2013
Q4 		– Sell
-96,755
Closed -$1.78M – 1363
2013
Q3 		$1.78M Buy
96,755
+14,230
+17% +$276K 0.02% 498
2013
Q2 		$1.44M Buy
+82,525
New +$1.46M 0.02% 548

Other funds holding ARIA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Los Angeles Capital Management's ARIA Position: Q3 2016 in Review

Los Angeles Capital Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2016, closing a stake of 14,545 shares — an estimated $107K sold.

Los Angeles Capital Management first reported a position in ARIA in Q2 2013 and held it in 3 quarters. The position peaked at $1.78M in Q3 2013. 202 funds tracked by Wall St. Rank hold ARIA as of Q3 2016.

  • Los Angeles Capital Management reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
  • Los Angeles Capital Management sold 14,545 Ariad Pharmaceuticals Inc shares in Q3 2016, an estimated $107K.
  • Los Angeles Capital Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 3 quarters.
  • Los Angeles Capital Management's Ariad Pharmaceuticals Inc position peaked at $1.78M in Q3 2013.
  • 202 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2016.

Based on Los Angeles Capital Management's 13F filing for Q3 2016, filed 9 Nov 2016.